Showing results (241-250 of 547) with videos related to
Sort By:
Pageof 55
Waste Management (New York, N.Y.)|December 5, 2018
Concentration of precious metals from waste printed circuit boards using supergravity separationLong Meng, Lei Guo, Yiwei Zhong, et al.Bioresources and Bioprocessing|July 25, 2025
The driving role of extracellular polymeric substances in the bioelectrical conversion of petroleum hydrocarbons by rhizosphere microbial fuel cells: bioelectricity production, substrate bioconversion, microbial function and their network correlationLanmei Zhao, Yuru Wen, Lyu Can, et al.Nucleic Acids Research|January 19, 2006
Saccharomyces cerevisiae Est3p dimerizes in vitro and dimerization contributes to efficient telomere replication in vivoCui-Ping Yang, Yong-Bin Chen, Fei-Long Meng, et al.Synthetic and Systems Biotechnology|February 19, 2025
Polyhydroxyalkanoate production during electroactive biofilm formation and stabilization in wetland microbial fuel cells for petroleum hydrocarbon bioconversionLanmei Zhao, Mengxue Sun, Can Lyu, et al.Cell|February 5, 2013
Mechanisms of programmed DNA lesions and genomic instability in the immune systemFrederick W Alt, Yu Zhang, Fei-Long Meng, et al.Sensors (Basel, Switzerland)|November 10, 2019
Guided, Fusion-Based, Large Depth-of-field 3D Imaging Using a Focal StackYuhao Xiao, Guijin Wang, Xiaowei Hu, et al.ACS Biomaterials Science & Engineering|January 9, 2021
Zwitterionic-Based Surface via the Coelectrodeposition of Colloid Particles and Tannic Acid with Bacterial Resistance but Cell Adhesion PropertiesLong Meng, Kai Pan, Ye Zhu, et al.Current Drug Targets|May 28, 2014
The synergistic effect of humanized monoclonal antibodies targeting insulin-like growth factor 1 receptor (IGF-1R) and chemotherapyPing Sui, Hongxin Cao, Long Meng, et al.STAR Protocols|September 24, 2023
A high-throughput protocol for deamination of long single-stranded DNA and oligo pools containing complex sequencesYanyan Wang, Senxin Zhang, Xiaoqi Zheng, et al.Scientific Reports|March 18, 2020
Safety Profile of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Disproportionality Analysis of FDA Adverse Event Reporting SystemJing Huang, Long Meng, Bing Yang, et al.Pageof 55